Literature DB >> 1123108

Hyperinsulinemia and enlarged adipocytes in patients with endogenous hyperlipoproteinemia without obesity or diabetes mellitus.

R S Bernstein, N Grant, D M Kipnis.   

Abstract

Studies of adipocyte metabolism were performed in twelve male subjects with normal plasma lipids and eleven male patients with Type IV or Type V hyperlipoproteinemia. Patients with obesity or diabetes mellitus were excluded from the study. Although all patients had normal glucose tolerance tests, the blood glucose levels during these tests were higher in the hyperlipoproteinemic patients than in the normal control subjects and the plasma insulin responses were even more strikingly elevated in the hyperlipemic group. Adipocytes isolated from hypertriglyceridemic subjects were larger than those obtained from normal individuals and exhibited increased activities of both Type I and Type II hexokinase and increased rates of glucose oxidation and lipogenesis from glucose. Cell size, hexokinase isoenzyme activities and rates of lipogenesis from glucose were all strongly correlated with each other, but none of these measurements were correlated with glucose oxidation. It is not known how the adipocyte abnormalities are related to the lipid transport disorder.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1123108     DOI: 10.2337/diab.24.2.207

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  2 in total

1.  Plasma Levels of Triglycerides and IL-6 Are Associated With Weight Regain and Fat Mass Expansion.

Authors:  Qi Qiao; Freek G Bouwman; Marleen A van Baak; Nadia J T Roumans; Roel G Vink; Edwin C M Mariman
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

2.  Biochemical and clinical characterization of metabolic phenotypes: a cross-sectional study from Maracaibo city, Venezuela.

Authors:  Valmore Bermudez; Joselyn Rojas; Juan Salazar; Maria Sofia Martinez; Luis Carlos Olivar; Maria Jose Calvo; Andres Mindiola; Roberto Añez; Sandra Wilches-Duran; Marcos Cerda; Modesto Graterol; Rosemily Graterol; Juan Diego Hernandez; Carlos Garicano; Manuel Velasco
Journal:  F1000Res       Date:  2018-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.